<DOC>
	<DOCNO>NCT02451748</DOCNO>
	<brief_summary>The purpose study well understand factor present cell inflamed joint patient arthritis may cause rheumatoid arthritis . Knowledge gain study may lead new good therapy arthritis .</brief_summary>
	<brief_title>IL-7 IL-7R Expression Peripheral Blood Mononuclear Cells , Peripheral Blood Monocytes Differentiated Macrophages Rheumatoid Arthritis Patients With Active vs. Inactive Disease Treated With DMARD and/or CIMZIA</brief_title>
	<detailed_description>Blood sample collect patient diagnose RA base ACR classification criterion . The study include 200 donor . The total number subject divide two group yield power 95 % type I error 5 % level [ determine base preliminary data ] . In first group , 200 donor treat methotrexate , plaquenil and/or prednisone ( DMARDs ) either achieve remission ( DAS28 &lt; 2.6 ) achieve remission ( DAS28 &gt; 2.6 ) . 50 donor utilized respond DMARDs achieve remission ( DAS28 &lt; 2.6 ) 150 donor respond DMARDs transfer second group . In second group , 150 donor treat methotrexate , plaquenil and/or prednisone Cimzia® ( provide u UCB ) . In first group patient , blood sample obtain RA patient treat Disease modify anti rheumatic drug ( DMARDs ) methotrexate , plaquenil and/or prednisone achieve remission ( DAS28 &lt; 2.6 ) . The patient achieve remission ( DAS28 &lt; 2.6 ) , blood take patient routine visit . The second group consist RA patient respond `` DMARDs '' . These patient receive ( DMARDs ) methotrexate , plaquenil and/or prednisone well Cimzia® ( provide u UCB ) free charge . Cimzia® FDA approve drug standard care . Blood sample obtain patient treated DMARDs include methotrexate , plaquenil , and/or prednisone Cimzia® ( provide u UCB ) inactive remission ( DAS28 &lt; 2.6 ) . In group , blood sample collect onset study well 3 6 month treatment Cimzia patient 's visit collaboration aforementioned rheumatologist . Patients receive intra-articular steroid injection exclude study . PB mononuclear cell isolate RA whole blood drawn EDTA CPT tubes isolate Histopaque gradient centrifugation . Monocytes isolate RA PB mononuclear cell negative selection ( show preliminary data ) half monocyte differentiate macrophage 7 day . The expression level IL-7 IL-7R determine real-time RT-PCR FACS analysis . In statistical analysis , first perform stratified analysis evaluate differential expression level RA patient active inactive disease , control type treatment . Data analysis perform collaboration UIC Center Clinical Translational Science statistician . Specifically , perform comparison IL-7 IL-7R expression among RA patient active ( DAS28 &gt; 2.6 ) vs. inactive disease ( DAS28 &lt; 2.6 ) DMARDs group ( group 1 ) . We perform similar comparison DMARDs Cimzia® therapy group ( group 2 ) . The stratified analysis adjust potential confounding effect treatment receive allows detection potential differential relationship expression level IL-7 IL-7R disease status . We also perform pooled regression analysis expression logarithm IL-7 IL-7R patient regress treatment group indicator [ DMARDs ( group 1 ) versus DMARDs plus Cimzia® therapy ( group 2 ) ] disease status ( active inactive disease ) would demonstrate interaction treatment group disease activity . Such analysis pool subject two treatment group together therefore increase sample size , hence potentially power detect relationship biomarkers disease status . The RA sample collect 2 year period data analyze last year proposal .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>1 . Must meet 1987 Revised Criteria Classification Rheumatoid Arthritis define diagnosis refer physician . 2 . Persistent knee swell ( &gt; ARA grade 2 ) 2 week , recent intraarticular corticosteroid injection . 3 . Age 18 year old . 4 . Must Disease modify anti rheumatic drug ( DMARDs ) methotrexate , plaquenil and/or prednisone . 1 . Patients receive intraarticular corticosteroid joint injection within last 24 week . 2 . Patients active systemic joint infection . 3 . Women pregnant ( pregnancy status selfreported ) 4 . Patients 18 year age 5 . NonEnglish speaker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>